North America Antimicrobial Susceptibilty Testing Market to 2032

Overview

The North America Antimicrobial Susceptibilty Testing Market is expected to reach a 2.57 USD Billion by 2032 and is projected to grow at a CAGR of 8.91% from 2025 to 2032.

Revenue, 2024 (USD Billion)
1.65
Forecast, 2032 (USD Billion)
2.57
CAGR, 2024 - 2032
8.91%
Report Coverage
North America

North America Antimicrobial Susceptibilty Testing Market 2018-2032 USD Billion

North America Antimicrobial Susceptibilty Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 1.65 USD Billion
  • Projected Market Size (2032): 2.57 USD Billion
  • CAGR (2025-2032): 8.91%

Key Findings of North America Antimicrobial Susceptibilty Testing Market

  • The North America Antimicrobial Susceptibilty Testing Market was valued at 1.65 USD Billion in 2024.
  • The North America Antimicrobial Susceptibilty Testing Market is likely to grow at a CAGR of 8.91% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Hospitals in End User Segment accounted for the largest share of the market with a revenue of 1.71 USD Billion
  • The fastest growing segment Third Party Distributor in Distribution Channel Segment grew Fastest with a CAGR of 9.89% during the forecast period from 2024 to 2032.

North America Antimicrobial Susceptibilty Testing Market Scope

North America Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Product Type
  • Service & Software
  • Instruments
  • Consumables & Accessories
Type
  • Others
  • Anti Bacterial Testing
  • Anti Fungal Testing
Method
  • Others
  • Mass Spectrometry Method
  • Dilution
  • Geneotypic Methods
  • E-Test
  • Disk Diffusion
Application
  • Others
  • Epidemiology
  • Drug Discovery and Development
  • Clinical Diagnostics
Distribution Channel
  • Third Party Distributor
  • Direct Sales
  • Retail Sales
End User
  • Others
  • Pharmaceutical & Biotechnology companies
  • Diagnostic Laboratories
  • Research Centres and Academic Institutes
  • Contract Research Organizations
  • Hospitals

North America Antimicrobial Susceptibilty Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 1.65 USD Billion
Market Value in 2032 2.57 USD Billion
CAGR (2025-2032) 8.91%
Historic Data 2016-2023
Market Segments Covered Product Type,Type,Method,Application,Distribution Channel,End User

Regional Insights:

  • Leading Market (2024-2032): North America, leading in terms of revenue 1.65 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 1,509.49 USD Million in 2024.

Segments and Scope

  • North America Antimicrobial Susceptibilty Testing Market to 2032, By Product Type
    • Consumables & Accessories is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.13 USD Billion in the year 2024.
    • Instruments is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.00 % in forecast period 2025-2032.
  • North America Antimicrobial Susceptibilty Testing Market to 2032, By Type
    • Anti Fungal Testing is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.49 USD Billion in the year 2024.
    • Anti Bacterial Testing is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 8.32 % in forecast period 2025-2032.
  • North America Antimicrobial Susceptibilty Testing Market to 2032, By Method
    • Disk Diffusion is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.58 USD Billion in the year 2024.
    • Disk Diffusion is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.63 % in forecast period 2025-2032.
  • North America Antimicrobial Susceptibilty Testing Market to 2032, By Application
    • Clinical Diagnostics is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.20 USD Billion in the year 2024.
    • Clinical Diagnostics is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 9.33 % in forecast period 2025-2032.
  • North America Antimicrobial Susceptibilty Testing Market to 2032, By Distribution Channel
    • Retail Sales is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.51 USD Billion in the year 2024.
    • Third Party Distributor is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 8.25 % in forecast period 2025-2032.
  • North America Antimicrobial Susceptibilty Testing Market to 2032, By End User
    • Hospitals is the largest segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 1.71 USD Billion in the year 2024.
    • Diagnostic Laboratories is the Fastest growing segment in North America Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 8.94 % in forecast period 2025-2032.

North America Antimicrobial Susceptibilty Testing Market Company Share Analysis

 
Company Name Company Share Analysis
Merck & Co., Inc.
Mast Group Ltd.
Liofilchem S.r.l.
Thermo Fisher Scientific Inc.
Rosco Diagnostica A/S
North America Antimicrobial Susceptibilty Testing Market Company Share Analysis

North America Antimicrobial Susceptibilty Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Antimicrobial Susceptibilty Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Antimicrobial Susceptibilty Testing Market Company Profiling

North America Antimicrobial Susceptibilty Testing Market Company Profiling
Frequently Asked Questions
The North America Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Product Type,Type,Method,Application,Distribution Channel,End User.
North America Antimicrobial Susceptibilty Testing Market was valued at USD 1.65(Revenue in USD Billion) in 2020.
North America Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 8.91% during the forecast period of 2024 to 2032.
The Hospitals segment is expected to dominate the North America Antimicrobial Susceptibilty Testing Market, holding a largest market share of 1.71 USD Billion in 2024

Coming Soon....

North America Antimicrobial Susceptibilty Testing Market Scope

North America Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Product Type
  • Service & Software
  • Instruments
  • Consumables & Accessories
Type
  • Others
  • Anti Bacterial Testing
  • Anti Fungal Testing
Method
  • Others
  • Mass Spectrometry Method
  • Dilution
  • Geneotypic Methods
  • E-Test
  • Disk Diffusion
Application
  • Others
  • Epidemiology
  • Drug Discovery and Development
  • Clinical Diagnostics
Distribution Channel
  • Third Party Distributor
  • Direct Sales
  • Retail Sales
End User
  • Others
  • Pharmaceutical & Biotechnology companies
  • Diagnostic Laboratories
  • Research Centres and Academic Institutes
  • Contract Research Organizations
  • Hospitals
Frequently Asked Questions
The North America Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Product Type,Type,Method,Application,Distribution Channel,End User.
North America Antimicrobial Susceptibilty Testing Market was valued at USD 1.65(Revenue in USD Billion) in 2020.
North America Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 8.91% during the forecast period of 2024 to 2032.
The estimated market value of the North America Antimicrobial Susceptibilty Testing Market for final year is USD 2.57 (USD Billion).

North America Antimicrobial Susceptibilty Testing Market Company Profiling

North America Antimicrobial Susceptibilty Testing Market Company Profiling
Frequently Asked Questions
The North America Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Product Type,Type,Method,Application,Distribution Channel,End User.
North America Antimicrobial Susceptibilty Testing Market was valued at USD 1.65(Revenue in USD Billion) in 2020.
North America Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 8.91% during the forecast period of 2024 to 2032.
The estimated market value of the North America Antimicrobial Susceptibilty Testing Market for final year is USD 2.57 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.